Skip to content

Comparison of the efficacy of cryotherapy and 0.1 % acnalen gel vs. cryotherapy alone in the treatment of actinic keratoses: a randomized, double-blind clinical trial

Comparison of the efficacy of cryotherapy and 0.1 % acnalen gel vs. cryotherapy alone in the treatment of actinic keratoses: a randomized, double-blind clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201010104901N1
Enrollment
100
Registered
2010-10-31
Start date
2010-01-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Actinic keratoses. Actinic keratoses

Interventions

Intervention 1: Cryotherapy at the beginning + Acnalene 0.1% gel twice daily for 3 months. Intervention 2: Control group: Cryotherapy at the begining + placebo twice daily for 3 months.
Treatment - Drugs
Placebo
Cryotherapy at the beginning + Acnalene 0.1% gel twice daily for 3 months
Control group: Cryotherapy at the begining + placebo twice daily for 3 months

Sponsors

Aburaihan Company
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Clinical diagnosis of actinic keratosis, At least 5 lesions, Willing to participate in the study Exclusion criteria: Pregnancy (first trimester), Previous history of allergy to drugs of study, Use of destructive methods or drugs for treatment of lesions over the last month, Use of Isotretinoine over the last 2 months, Use of peeling methods over the last month, Participation in the other clinical studies over the past month

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Clearance of lesions. Timepoint: Baseline and then monthly. Method of measurement: Number of lesions.

Secondary

MeasureTime frame
Side effects. Timepoint: Monthly. Method of measurement: Medical history and physical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahnaz Jaberian

Tabriz University of Medical Sciences

jaberian_m@hotmail.com+98 44 1331 1819

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026